SCHEMBL14101540

SCHEMBL14101540

c1cc(-c2ccc3sc4ccc(-c5ccc6ccccc6c5)cc4c3c2)cc(-c2ccc3ccc4cccc5ccc2c3c45)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR5 Q9H228 10/20 0.40
S1PR4 O95977 7/20 0.40
HSD17B1 P14061 2/20 0.40
HSD17B2 P37059 2/20 0.40
GSTP1 P09211 1/20 0.38
ERBB2 P04626 1/20 0.37
CYP1A2 P05177 1/20 0.37
FYN P06241 1/20 0.37
MAOA P21397 1/20 0.37
ACHE P22303 1/20 0.37
AHR P35869 1/20 0.37
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
CYP17A1 P05093 1/20 0.35
CYP19A1 P11511 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
ALOX5 P09917 1/20 0.34
F9 P00740 1/20 0.33
HDAC4 P56524 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101529 0.97 S1PR5 (0.41) S1PR5S1PR4HSD17B1HSD17B2GSTP1
SCHEMBL14101441 0.96 S1PR5 (0.42) S1PR5S1PR4HSD17B1HSD17B2GSTP1
SCHEMBL14101456 0.95 S1PR5 (0.40) S1PR5S1PR4HSD17B1HSD17B2GSTP1
SCHEMBL14101463 0.95 S1PR5 (0.40) S1PR5S1PR4HSD17B1HSD17B2GSTP1
SCHEMBL14101443 0.94 CYP1A2 (0.38) S1PR5S1PR4HSD17B1HSD17B2ERBB2
SCHEMBL14101658 0.94 CYP1A2 (0.38) S1PR5S1PR4HSD17B1HSD17B2ERBB2
SCHEMBL14101460 0.94 S1PR5 (0.38) S1PR5S1PR4HSD17B1HSD17B2GSTP1
SCHEMBL14101453 0.94 S1PR5 (0.38) S1PR5S1PR4HSD17B1HSD17B2GSTP1
SCHEMBL14101474 0.94 CYP1A2 (0.38) S1PR5S1PR4HSD17B1HSD17B2ERBB2
SCHEMBL14101476 0.93 F9 (0.39) S1PR5S1PR4HSD17B1HSD17B2ERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME CYBA, BPNT1, TYR S1PR5 4736/4885S1PR4 4464/4885HSD17B1 865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.